Literature DB >> 20161258

Craving Predicts Within Session Drinking Behavior Following Placebo.

Robert F Leeman1, William R Corbin, Kim Fromme.   

Abstract

Tiffany's (1990) cognitive processing model postulates that craving will only occur when access to alcohol is blocked. To test a hypothesis based on this model, we analyzed data from a naturalistic laboratory alcohol challenge study involving moderate-to-heavy drinking young adults (N = 174) with a focus on the placebo beverage condition of this study. Our hypothesis was that self-reports of "wanting more alcohol" (i.e., craving) in the lab, following placebo, would predict subsequent ad libitum consumption because placebo administration would constitute partial blocking of access to alcohol. We also tested the possibility that craving might mediate associations between personality traits and ad libitum consumption. Both trait disinhibition and reports of craving following the placebo beverage significantly predicted ad libitum consumption. Further, craving partially mediated the association between trait disinhibition and ad libitum consumption. Potential implications of these findings are discussed.

Entities:  

Year:  2009        PMID: 20161258      PMCID: PMC2699682          DOI: 10.1016/j.paid.2009.01.024

Source DB:  PubMed          Journal:  Pers Individ Dif        ISSN: 0191-8869


  23 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  The influence of traits of disinhibition on the association between alcohol use and risky sexual behavior.

Authors:  A N Justus; P R Finn; J E Steinmetz
Journal:  Alcohol Clin Exp Res       Date:  2000-07       Impact factor: 3.455

Review 3.  Student factors: understanding individual variation in college drinking.

Authors:  John S Baer
Journal:  J Stud Alcohol Suppl       Date:  2002-03

Review 4.  Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches.

Authors:  Ingmar H A Franken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-06       Impact factor: 5.067

5.  The balanced placebo design: methodological considerations.

Authors:  D J Rohsenow; G A Marlatt
Journal:  Addict Behav       Date:  1981       Impact factor: 3.913

Review 6.  Theories of drug craving, ancient and modern.

Authors:  D C Drummond
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

7.  The effects of alcohol and expectancies on risk perception and behavioral skills relevant to safer sex among heterosexual young adult women.

Authors:  Stephen A Maisto; Michael P Carey; Kate B Carey; Christopher M Gordon
Journal:  J Stud Alcohol       Date:  2002-07

8.  Dissociation of "conscious desire" (craving) from and relapse in alcohol and cocaine dependence.

Authors:  N S Miller; M S Gold
Journal:  Ann Clin Psychiatry       Date:  1994-06       Impact factor: 1.567

9.  Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment.

Authors:  Miriam Bottlender; Michael Soyka
Journal:  Alcohol Alcohol       Date:  2004 Jul-Aug       Impact factor: 2.826

10.  Drug preference and mood in humans: diazepam.

Authors:  C E Johanson; E H Uhlenhuth
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  17 in total

1.  Influence of sensation seeking on response to alcohol versus placebo: implications for the acquired preparedness model.

Authors:  Caitlin Scott; William R Corbin
Journal:  J Stud Alcohol Drugs       Date:  2014-01       Impact factor: 2.582

2.  Craving, cortisol and behavioral alcohol motivation responses to stress and alcohol cue contexts and discrete cues in binge and non-binge drinkers.

Authors:  Sara K Blaine; Nisheet Nautiyal; Rachel Hart; J B Guarnaccia; Rajita Sinha
Journal:  Addict Biol       Date:  2018-08-09       Impact factor: 4.280

Review 3.  Evidence for incentive salience sensitization as a pathway to alcohol use disorder.

Authors:  Roberto U Cofresí; Bruce D Bartholow; Thomas M Piasecki
Journal:  Neurosci Biobehav Rev       Date:  2019-10-28       Impact factor: 8.989

4.  Increased behavioral economic demand and craving for alcohol following a laboratory alcohol challenge.

Authors:  Michael Amlung; Kayleigh N McCarty; David H Morris; Chia-Lin Tsai; Denis M McCarthy
Journal:  Addiction       Date:  2015-04-07       Impact factor: 6.526

5.  Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.

Authors:  Marc I Kruse; Alexander J Radnovich; Raj K Kalapatapu; Nicole Mehdiyoun; R Andrew Chambers; Dena Davidson
Journal:  J Stud Alcohol Drugs       Date:  2012-03       Impact factor: 2.582

6.  Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

Authors:  Robert Miranda; Hayley Treloar Padovano; Joshua C Gray; Stephanie E Wemm; Alexander Blanchard
Journal:  Addict Behav       Date:  2018-01-10       Impact factor: 3.913

7.  Alcohol craving in adolescents: bridging the laboratory and natural environment.

Authors:  Jason Ramirez; Robert Miranda
Journal:  Psychopharmacology (Berl)       Date:  2013-12-22       Impact factor: 4.530

8.  A multilevel structural equation model of within- and between-person associations among subjective responses to alcohol, craving, and laboratory alcohol self-administration.

Authors:  Jeffrey D Wardell; Vijay A Ramchandani; Christian S Hendershot
Journal:  J Abnorm Psychol       Date:  2015-11

9.  A human alcohol self-administration paradigm to model individual differences in impaired control over alcohol use.

Authors:  Robert F Leeman; William R Corbin; Christine Nogueira; Suchitra Krishnan-Sarin; Marc N Potenza; Stephanie S O'Malley
Journal:  Exp Clin Psychopharmacol       Date:  2013-08       Impact factor: 3.157

10.  Using Placebo Beverages in Group Alcohol Studies.

Authors:  Molly A Bowdring; Michael A Sayette
Journal:  Alcohol Clin Exp Res       Date:  2018-10-17       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.